DEFM14A: Regional Health Properties and SunLink Health Systems Announce Merger Agreement and Shareholder Vote Details

Regional Health Properties, Inc. and SunLink Health Systems, Inc. have finalized an amended merger agreement, outlining a stock-for-stock exchange and new preferred shares, with shareholder votes scheduled for July 29, 2025, despite Regional's recent NYSE American delisting.

Summary

• Regional Health Properties, Inc. (Regional) and SunLink Health Systems, Inc. (SunLink) entered into an Amended and Restated Agreement and Plan of Merger on April 14, 2025, with Regional set to acquire SunLink.
• Each five shares of SunLink common stock will be converted into 1.1330 shares of Regional common stock and one share of Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares.
• The number of Regional Series D preferred shares is subject to upward adjustment if SunLink's cash and cash equivalents exceed $7,500,000 at closing, at a rate of one Series D share for every $10.00 of cash surplus, though SunLink does not expect to exceed this amount.
• SunLink may pay special cash dividends to its shareholders prior to closing, totaling up to $1,000,000, with an anticipated amount of approximately $0.10 per SunLink share.
• Post-merger, former SunLink shareholders are expected to own approximately 43.06% of the outstanding Regional common stock.
• Special shareholder meetings for both companies are scheduled for July 29, 2025, at 10:00 a.m. Eastern time, to approve the merger and related proposals.
• Both Regional's and SunLink's Boards of Directors unanimously recommend voting FOR the merger proposals.
• Directors and executive officers of Regional (representing ~13.5% voting power) and SunLink (representing ~23.3% voting power) have entered into support and lock-up agreements to vote in favor of the merger.
• The merger is intended to qualify as a tax-free reorganization for U.S. federal income tax purposes, except for cash received in lieu of fractional shares.
• Regional's common stock and Series A preferred stock were delisted from NYSE American on June 11, 2025, and now trade on OTCQB; Regional will seek OTC trading for Series D preferred stock and NYSE American listing for common stock post-merger.
• SunLink common stock will cease to be listed on NYSE American and will be deregistered after the merger.
• SunLink shareholders may be entitled to dissenters' rights under Georgia law, with a limit of not more than 2,000,000 shares exercising such rights for the merger to close.
• Key closing conditions include shareholder approvals, no prohibitive governmental orders, SEC effectiveness of the Form S-4, Regional shares authorized for OTC trading or NYSE listing, SunLink cash of at least $6,000,000, SunLink pharmacy working capital of at least $2,500,000, and Regional repurchasing at least 500,000 Series B preferred shares.
• The merger agreement's termination date has been extended to August 11, 2025.

Sentiment

Score: 3

Explanation: The document outlines a merger between two financially challenged companies, both with histories of operating losses and significant risks. Regional has been delisted from NYSE American and has debt covenant violations. SunLink's financial advisor's valuation yielded a negative enterprise value. While the merger aims for synergies and diversification, the immediate financial outlook for the combined entity is negative, and there are numerous significant risks highlighted, including the uncertainty of realizing benefits and the potential for further financial strain.

Positives

• Both Regional and SunLink Boards of Directors unanimously recommend the merger, indicating strong internal support.
• The merger is structured with a fixed exchange ratio for common stock, providing certainty on the share allocation for SunLink shareholders.
• The transaction is intended to qualify as a tax-free reorganization for U.S. federal income tax purposes for SunLink shareholders, minimizing immediate tax implications on the stock exchange.
• The combined company is expected to benefit from complementary business lines and the long-term care experience of senior management, potentially leading to operational synergies.
• The merger offers a potential opportunity for Regional shareholders to participate in increased valuation and cash flows, with a possibility for the combined entity to become net income positive.
• SunLink shareholders may receive a special cash dividend of approximately $0.10 per share prior to the closing, providing immediate cash return.
• The Lenox Group, SunLink's financial advisor, issued an opinion that the merger consideration is fair to SunLink shareholders from a financial point of view.

Negatives

• Regional has a history of operating losses, with a net loss of $(3,218) thousand in 2024 and $(3,888) thousand in 2023.
• Regional's common stock and Series A preferred stock were delisted from NYSE American on June 11, 2025, and now trade on OTCQB, indicating significant financial challenges and reduced market visibility.
• Regional carries substantial indebtedness of $49,721 thousand as of December 31, 2024, and has faced loan covenant violations, leading to a notice of acceleration on its Southland facility loan.
• SunLink also has a history of operating losses, with a net loss of $(1,527) thousand in 2024 and $(1,795) thousand in 2023, and expects these losses to continue.
• SunLink's financial advisor's discounted cash flow analysis yielded a negative enterprise valuation for SunLink, and its comparable company analysis found SunLink to have the lowest enterprise value based on EBITDA (0.2x) among peers.
• SunLink's management does not expect its significant federal ($29,217 thousand) and state ($45,800 thousand) net operating loss carry-forwards to be utilized.
• The value of the merger consideration is highly dependent on the fluctuating market price of Regional common stock and the unlisted Regional Series D preferred stock, introducing significant uncertainty for SunLink shareholders.
• The conversion ratio of the Regional Series D preferred stock can be reduced if Regional fails to achieve a National Market Listing by specified milestone dates, potentially diluting its value.
• SunLink shareholders will have a reduced ownership and voting interest (approximately 43.06%) in the combined company post-merger.
• The merger is subject to numerous conditions, and failure to satisfy them could lead to delays or termination, resulting in significant costs for both parties.
• Both companies are subject to contractual restrictions on their business conduct during the merger's pendency, which could adversely affect operations.
• The fairness opinion from The Lenox Group is based on data as of March 4, 2025, and does not reflect subsequent changes or future circumstances.
• SunLink's pharmacy business is highly dependent on a single key supplier, accounting for 76-77% of its cost of goods sold, posing a concentration risk.
• SunLink's pharmacy business is vulnerable to changes in government reimbursement regulations, managed care contracting, and average wholesale prices (AWP), which could reduce revenues and profitability.

Risks

• The full strategic and financial benefits expected from the merger may not be realized, or may take longer to achieve than anticipated, potentially leading to dilution of Regional's earnings per share.
• Significant direct and indirect costs will be incurred by both Regional and SunLink in connection with the merger, regardless of whether it is completed, potentially depleting cash resources.
• Litigation related to the merger, including threatened shareholder lawsuits, could result in substantial costs and delays, or even prevent the merger's consummation.
• The value of the Regional common stock and the newly issued Regional Series D preferred stock in the merger consideration is subject to market fluctuations and is not guaranteed.
• The Regional Series D preferred stock is a newly issued security with no current public market, making its value uncertain.
• The merger is subject to various closing conditions, including shareholder and regulatory approvals, which may not be satisfied or waived, potentially delaying or preventing the transaction.
• Contractual restrictions on the conduct of business for both Regional and SunLink during the pre-closing period may adversely affect their operations and ability to pursue other opportunities.
• The merger could divert significant management attention from day-to-day activities, potentially harming the businesses of both companies.
• Interests of certain directors and executive officers in the merger may differ from those of general shareholders, creating potential conflicts of interest.
• Sales of Regional common stock and Regional Series D preferred stock by former SunLink shareholders after the merger could depress their market prices.
• There is a risk that the merger may not qualify as a tax-free reorganization under Section 368(a) of the Code, which could result in tax liability for SunLink, Regional, and/or their shareholders.
• The fairness opinion obtained by SunLink's strategic planning committee does not reflect changes, circumstances, or events that may occur after its March 4, 2025 date.
• SunLink shareholders may exercise dissenters' rights, potentially impacting the merger if the number of dissenting shares exceeds the 2,000,000 share threshold.
• Regional's portfolio stabilization measures expose it directly to the various risks faced by its tenants, including financial difficulties, operational challenges, and regulatory non-compliance.
• Regional is highly dependent on specific tenants (Aspire and C.R. Management) for a significant portion of its revenues, and their inability to meet obligations could materially affect Regional.
• Public health crises, epidemics, and pandemics (like COVID-19) can adversely impact occupancy rates, increase operational costs, and heighten the risk of tenant bankruptcy or insolvency.
• Increased competition and rising operating costs in the long-term care industry could negatively affect tenants' ability to meet their lease obligations to Regional.
• Natural or man-made disasters could harm facilities, requiring costly evacuations or repairs, and potentially leading to uninsured losses.
• Regional may be named as a defendant in litigation involving services provided by its tenants, with potential liabilities exceeding insurance coverage.
• If Regional must replace tenants, it may face delays, increased expenses, and difficulty finding suitable replacements on favorable terms due to regulatory hurdles and property customization.
• Regional's substantial indebtedness ($49.7 million) increases its vulnerability to adverse economic conditions and limits its financial flexibility and ability to obtain additional financing.
• Regional has a history of operating losses and may not have sufficient liquidity to meet its capital needs, relying on uncertain future cash flows, debt refinancing, and asset sales.
• Covenants in Regional's debt agreements limit its operational flexibility, and a breach could materially adversely affect its business.
• Regional's real estate investments are relatively illiquid, making it difficult to sell properties quickly in response to changing conditions.
• The market price of Regional's common stock and Series A preferred stock has fluctuated, and future declines could impair its ability to raise capital.
• Regional is a holding company dependent on dividends and distributions from its subsidiaries, which may be restricted by debt agreements.
• Ownership and transfer restrictions in Regional's articles of incorporation may prevent or restrict acquisitions or transfers of shares.
• Provisions in Georgia law and Regional's organizational documents may delay or prevent a change in control or management.
• Future transactions by Regional to regain NYSE American listings could result in significant dilution to existing shareholders.
• The costs of being a publicly owned company may strain Regional's resources and impact its financial condition.
• Loss of key management personnel could adversely affect Regional's ability to manage its business and achieve objectives.
• Regional's directors and officers substantially control major decisions, potentially deterring hostile takeovers.
• SunLink's operations continue to be negatively affected by the aftermath of the COVID-19 pandemic, including labor shortages, rising costs, and supply chain disruptions.
• SunLink's reliance on Medicare and Medicaid payments makes its revenues vulnerable to reductions in government reimbursement rates and cost-containment initiatives.
• Changes in pharmacy distribution and dispensing, including actions by Pharmacy Benefit Managers (PBMs) and industry consolidation, may adversely affect SunLink's pharmacy business.
• Continued supply chain shortages could increase SunLink's operating costs or adversely affect its results if costs cannot be passed on to customers.
• SunLink's pharmacy business is highly dependent on a single key supplier, and the loss of this supplier could materially affect its operations.
• The loss of one or more large institutional pharmacy customers could significantly reduce SunLink's revenues and profitability.
• Failure to maintain eligibility as a Medicare and Medicaid supplier could materially adversely affect SunLink's competitive position.
• Changes in average wholesale prices (AWP) could reduce SunLink's pricing and margins in its pharmacy business.
• SunLink's pharmacy market may grow slower than expected, impacting revenues.
• A decrease in the introduction of new brand name and generic prescription drugs could adversely affect SunLink's pharmacy business profitability.
• SunLink has a limited corporate staff and depends heavily on subsidiary management, making it vulnerable to the loss of key personnel.
• SunLink's subsidiaries are subject to potential claims for professional liability, which may not be fully covered by insurance, and premiums for such insurance are volatile.

Future Outlook

The combined company aims to generate increased cash flows and potentially achieve net income positive status. Regional will use reasonable best efforts to obtain a National Market Listing for its common stock on NYSE American and to have its Series D preferred stock approved for trading on the OTC markets. The merger is expected to ensure an orderly transition of governance and ownership at Regional for the benefit of public shareholders.

Management Comments

• SunLink's management and the SunLink Board have long been concerned that the rural for-profit hospital sector in which SunLink had operated since 2001 was becoming less desirable as such sector broadly appeared to be underperforming financially, and that this particularly was the case with SunLink's rural hospitals.
• SunLink's Board concluded that to warrant the significant overhead costs of operating as a public company, it needed to actively pursue one or more extraordinary corporate transactions to expand its business, any of which transactions could involve an acquisition or a merger or consolidation with a compatible third party.
• Mr. Thornton (SunLink CEO) believed no transaction could realistically be considered seriously with Regional until Regional had successfully completed an exchange offer or other arrangement with its preferred shareholders to effect a conversion into common equity or effect some other resolution to thereby eliminate over $100 million of preferred equity and dividend arrearages.
• SunLink's management did not believe Regional was far enough along with its effort to restructure its balance sheet to be in a condition with which to enter into serious negotiations.
• SunLink's management believed a merger with Regional, if it could be successfully completed and implemented, offered substantial potential for an increase in shareholder value while he had low confidence in the projected outcome of a liquidation which carried substantial risks as to the timing and amount of distributions and offered little or no upside opportunity.
• SunLink's management believed Regional's valuation on the NYSE American, like SunLink's, was undervalued, and that merger should be based on net asset values of Regional and SunLink rather than on traded market values.
• SunLink's management believed the likely exit strategy for Regional once its balance sheet was improved would be a purchase by a larger company, and that asset values were a better measure of value in such event.
• SunLink's management noted that the timing and price of a sale of SunLink's business operations would be uncertain, that an announcement that SunLink was seeking shareholder authorization of a liquidation would likely have an adverse impact on sales and vendors, would make it more difficult to retain essential staff, and that significant additional expense likely would be required to retain existing staff or replace departing staff under a liquidation scenario.
• Regional's management anticipates access to, and receipt of, several sources of liquidity, including cash from operations and cash on hand.
• Regional's management anticipates that these actions, if successful, will provide the opportunity to maintain its liquidity, thereby permitting it to better meet its operating and financing obligations.

Industry Context

The merger represents a strategic shift for SunLink, moving away from its underperforming rural hospital sector and leveraging its pharmacy business within a larger healthcare real estate entity. For Regional, it signifies a diversification of its investment portfolio beyond long-term care and senior housing real estate into healthcare services, specifically pharmacy operations. The document highlights the challenging environment for rural hospitals and the increasing cost containment pressures from Pharmacy Benefit Managers (PBMs) on independent pharmacies, suggesting a consolidation trend in the healthcare services sector.

Comparison to Industry Standards

• The Lenox Group's comparable companies analysis found limited comparability between SunLink and selected publicly traded companies (AdaptHealth, VieMed, Infusystem Holdings, CVS Health, Walgreens Boots Alliance, CareRx, HealthWarehouse.com, Cognizant Technology Solutions, DXC Technology, Evolent Health, Omnicell) due to significant differences in geographical diversification, historical financial performance, end market mix, industry, and market capitalization.
• SunLink alone had a negative enterprise value based on sales (0.0x) and the lowest enterprise value based on EBITDA (0.2x) among the comparable precedent transactions reviewed, contrasting with the positive EBITDA margins observed in all included healthcare technology precedent transactions.
• The Lenox Group's precedent transaction analysis concluded that its analysis of long-term care transactions was directly comparable for valuing Regional, but not for valuing SunLink's core business.
• SunLink's management believed that Regional's valuation on NYSE American was undervalued, similar to SunLink's, and that asset values, rather than traded market values, were a better measure for the merger, aligning with their experience that nursing homes were selling at values exceeding operational values.
• SunLink's internal estimates for Regional's nursing homes, based on per-bed values, ranged from $59,131 to $107,575 per bed, with a midpoint of $83,353, derived from facility sale transactions and industry knowledge, including SunLink's own nursing home sales.

Management Changes

Corporate Governance

Legal Proceedings

• Regional is a defendant in various legal actions and administrative proceedings arising in the ordinary course of business, including claims that services provided during its time operating skilled nursing facilities resulted in injury or death to former patients.
• As of March 31, 2025, Regional is a defendant in one professional and general liability action directly related to patient care provided by its current or prior tenants.
• Two lawsuits against Regional, pertaining to facilities it transitioned operations to other entities, were nonsuited by the plaintiff in August 2024 and dismissed without prejudice, with the plaintiff having until August 2025 to re-file each matter.
• SunLink and its subsidiaries are subject to various claims and litigation that arise from time to time in the ordinary course of business, including tax, contract, workers compensation, and medical malpractice claims.
• SunLink has been subject to threatened claims in connection with the proposed merger and the adequacy of the disclosure in this joint proxy statement/prospectus, and may also be subject to actual claims asserted in connection therewith.

Related Party Transactions

• Regional's director, Steven L. Martin, is affiliated with holders of Regional Series B preferred stock, and Regional previously negotiated an exchange offer with Series A preferred stock holders, including affiliates of Mr. Martin.
• Regional's Chief Executive Officer, President, and Chairman, Brent S. Morrison, personally owns $70,000 aggregate principal amount of City of Springfield Ohio, First Mortgage Revenue Bonds (Eaglewood Property Holdings, LLC Project) Series 2012A, and $140,000 through ZCM Opportunities Fund, LP, over which he exercises discretion. These bonds are secured by the Eaglewood Village facility.
• A former director of SunLink (resigned July 2024) is senior counsel in a law firm that provides services to SunLink. SunLink expensed $520,000 and $264,000 to this law firm in the fiscal years ended June 30, 2024 and 2023, respectively. Amounts payable to the law firm were $156,000 as of June 30, 2024, and $36,000 as of June 30, 2023.

Stakeholder Impact

• **Shareholders (SunLink)**: Will receive a combination of Regional common stock and a new Series D preferred stock, resulting in a reduced ownership and voting interest (approximately 43.06%) in the combined company. They may also receive a special cash dividend prior to closing and may have dissenters' rights.
• **Shareholders (Regional)**: Will experience dilution in their ownership percentage due to the issuance of shares to SunLink shareholders. Their investment value will be tied to the performance of the combined entity, which carries significant financial risks and a history of losses.
• **Employees (SunLink)**: Key executives, Mark J. Stockslager (CFO) and Robert M. Thornton (CEO), will transition to leadership roles in the combined company. Other SunLink equity awards will be cancelled without consideration, though unvested 401(k) balances may vest. The merger could lead to changes in employment terms and benefits for other employees.
• **Employees (Regional)**: Brent S. Morrison (CEO) will continue in his role. The merger may bring new colleagues and potentially new operational structures.
• **Management**: Key management from both companies will form the leadership of the combined entity, with new employment agreements and potential conflicts of interest related to merger-specific benefits.
• **Creditors**: Regional's existing substantial debt and past covenant violations, combined with the new preferred stock, could impact the risk profile for creditors. The formation of a special committee with authority to sell facilities to redeem preferred stock introduces a new dynamic for asset management and debt repayment.
• **Customers/Patients**: The merger aims to expand services and potentially improve operational efficiency, which could benefit patients. However, ongoing industry challenges like labor shortages and cost pressures may affect service delivery.
• **Suppliers**: SunLink's pharmacy business has a high dependence on a single key supplier, making it vulnerable to disruptions in that relationship. The merger could lead to renegotiation of supplier contracts or changes in procurement strategies.
• **Regulatory Bodies**: The merger requires various regulatory approvals, and ongoing compliance with federal and state healthcare laws will be critical for the combined entity's operations.

Next Steps

• Regional and SunLink will hold special shareholder meetings on July 29, 2025, to vote on the merger and related proposals.
• Regional is expected to issue approximately 1,595,400 shares of Regional common stock and 1,408,121 shares of Regional Series D preferred stock to SunLink shareholders upon merger completion.
• Regional will issue 100,000 shares of Regional common stock to Mr. Robert Thornton pursuant to an employment agreement at closing.
• Regional is required to repurchase not fewer than 500,000 shares of Regional Series B preferred stock on or within five business days after the merger closing.
• Mark J. Stockslager will be appointed Chief Financial Officer and principal financial officer of the combined company.
• Robert M. Thornton will serve as Executive Vice President – Corporate Strategy of the combined company.
• The Regional Board will consist of seven directors post-merger, including two SunLink Designees and two Mutual Designees.
• A Regional Special Committee will be created to oversee the redemption/repurchase of Regional Series B and D preferred stock and direct the sale of Regional Facilities to generate funds for such redemptions/repurchases.
• Regional will use reasonable best efforts to cause its common stock to be approved for OTC trading prior to the effective time, and thereafter for listing on NYSE American.
• Regional will use reasonable best efforts to cause its Series D preferred stock to be approved for trading on the OTC within sixty days after the effective time.
• SunLink common stock will be delisted from NYSE American and deregistered under the Exchange Act promptly after the effective time.
• SunLink may pay one or two special cash dividends to its shareholders prior to the closing of the merger.
• SunLink will take action to cause all unvested balances in its 401(k) plan to become vested upon the closing of the merger, if requested by Regional.
• Regional will indemnify SunLink's directors and executive officers and maintain D&O insurance for them for six years post-merger.
• Regional and SunLink intend to file final voting results with the SEC on a Current Report on Form 8-K within four business days of the special meetings.

Key Dates

Recommendation

Keywords

Merger, Acquisition, Healthcare Real Estate, Pharmacy Services, Skilled Nursing Facilities, Senior Housing, SEC Filing, Proxy Statement, Regional Health Properties, SunLink Health Systems, Stock Exchange, Preferred Stock, Corporate Governance, Risk Management, Financial Performance, Shareholder Vote, Delisting, OTCQB, NYSE American, Debt, Liquidity, Dissenters Rights, Tax Reorganization, Real Estate Investment Trust, REIT, Healthcare Industry, Financial Advisory, Management Changes, Support Agreement, Lock-up Agreement, Dividend, Working Capital, Operating Losses, Supply Chain, Labor Shortages, Regulatory Compliance, Environmental Liabilities, Cybersecurity, Patient Care, Medicare, Medicaid, PBMs